date:Aug 19, 2013
w processing volumes and revenue earned during the quarter. On 24 May 2013, BioExx ceased production at the plant.
Cost of goods sold for the quarter decreased due to the low processing volumes and reduced scope of operations.
Gross loss for the quarter was $47,771, versus $466,603 for the comparable prior year period.
Net loss for the quarter was $8,479,078, versus $3,856,763 in Q2 2012, reflecting primarily the impairment provisions taken during the quarter, as well as the cumulative impact